0000935836-24-000317.txt : 20240326
0000935836-24-000317.hdr.sgml : 20240326
20240326120009
ACCESSION NUMBER: 0000935836-24-000317
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240326
DATE AS OF CHANGE: 20240326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital, LLC
CENTRAL INDEX KEY: 0001587114
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 24782137
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
3
1
ownership.xml
X0206
3
2024-03-08
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001587114
EcoR1 Capital, LLC
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
Ordinary Shares
164424420
I
See Note
These Ordinary Shares are held through 27,404,070 American Depository Shares, each representing 6 Ordinary Shares.
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") and Oleg Nodelman. EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself and the other reporting person. The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 3d-5(b) under the Securities and Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
Qualified Fund beneficially owns 155,106,660 Ordinary Shares.
/s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC
2024-03-25